Q3 2021 Astria Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Q3 2021 Astria Therapeutics Earnings Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Andrea Matthews, Senior Vice President, Corporate Affairs. Please go ahead.
Thank you, Elissa. Welcome to today's Astria Therapeutics conference call where we will provide a corporate update and review our third quarter 2021 financial results. With me today are Jill Milne, Chief Executive Officer; Andy Nichols, Chief Scientific Officer; Andrew Komjathy, Chief Commercial Officer; and Noah Clauser, Chief Financial Officer.
We issued a press release this morning summarizing our corporate update and our Q3 2021 financial results, which we will reference on today's call and is available on our website. We are also using slides during today's call that are available within the Events and Presentations section in the Investors part of our website.
I would like to note
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |